Shilpa Medicare Ltd share price logo

Shilpa Medicare Ltd (SHILPAMED)

₹572.38.65%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Insights on Shilpa Medicare Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.69% to 9.68% in Apr 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -8.04 Cr → 24.5 Cr (in ₹), with an average increase of 238.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SHILPAMED has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 1.59% to 5.01% in Apr 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 288.7 Cr → 300.32 Cr (in ₹), with an average increase of 3.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 124.0% return, outperforming this stock by 125.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SHILPAMED stock has moved down by -3.7%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 50.01% to 44.39% in Apr 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 42.62% to 38.39% in Apr 2024 quarter

Performance

  • Day's Low

    Day's High

    ₹523.15
    ₹576
  • 52 Week's Low

    52 Week's High

    ₹239.2
    ₹576
1 Month Return+ 7.13 %
3 Month Return+ 17.04 %
1 Year Return+ 98.81 %
Previous Close₹526.75
Open₹526.75
Volume9.23L
Upper Circuit-
Lower Circuit-
Market Cap₹5,151.14Cr

Company Information

Shilpa Medicare Limited (SML) was established in 1987 and converted to a public limited company in 1993. They are one of the leading API and formulations manufacturers, with expertise in oncology and non-oncology medicines, with over 44 APIs and 16 injectable dosage forms and 19 oral solid dosage forms. SML deploy sophisticated technology in order to comply with international standards. In 2015, funds were raised by allotting 1.76 Mn equity shares at Rs. 423/ share, and in 2016, the face value of equity shares was split into two equity shares of Rs.1/ each. Raichem Medicare Pvt. Ltd., a subsidiary of SML successfully installed all machinery and recruited personnel. During FY16, they launched generic versions of Vidaza Injection and Xeloda Tablets. In 2017, Navya Biologicals Private Limited was acquired and in 2019, they invested Rs 22.71 cr in Shilpa Therapeutics Pvt. Ltd and disinvested 24% stake in Raichem Medicare Pvt. Ltd. In 2021, they launched a pediatric dose paracetamol oral thin film, Molshil and acquired stake in FTF Pharma Pvt. Ltd, Koanaa Healthcare Canada, etc. In 2022, they approved Slump sale of Active Pharmaceutical Ingredient API Business to Shilpa Pharma Lifesciences Limited.

Share Price: ₹572.30 per share as on 20 Jun, 2024 04:01 PM
Market Capitalisation: ₹5,151.14Cr as of today
Revenue: ₹291.69Cr as on March 2024 (Q1 24)
Net Profit: ₹24.50Cr as on March 2024 (Q1 24)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
OrganisationShilpa Medicare Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Shilpa Medicare Ltd

  • Shilpa Medicare Shares Surge on Filing First DMF with USFDA - 05 Jun, 2024

    Shilpa Medicare's wholly-owned subsidiary, Shilpa Biologicals, filed its first Drug Master File (DMF) of recombinant Human Albumin 20% with the United States Food and Drug Administration. The company reported a consolidated net profit of Rs 24.50 crore in Q4 FY24 as against a net loss of Rs 8.04 crore posted in Q4 FY23.

  • Shilpa Medicare Reports Strong Financial Results for March 2024 Quarter - 28 May, 2024

    Shilpa Medicare reports a YoY increase of 10.67% in net sales, with quarterly net profit up by 404.68%. The company's EPS has also increased from Rs. 0.93 to Rs. 2.82. Shilpa shares have given returns of 34.52% over the last 6 months and 104.52% over the last 12 months.

  • Shilpa Medicare Reports Strong Financial Results - 24 May, 2024

    Shilpa Medicare reported strong financial results for Q4FY24 and standalone March 2024 with significant growth in revenue and profits. The stock has given returns of 36.32% over the last 6 months and 105.72% over the last 12 months.

  • Shilpa Medicare to Release Q4 Financial Results - 23 May, 2024

    Shilpa Medicare is set to release its fourth-quarter financial results on May 23, 2024, along with at least 180 other companies.

Shilpa Medicare Ltd Valuation

Shilpa Medicare Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-6579.29x)

March 28, 2024

Industry (65.08x)

June 19, 2024

Today (143.14x)

June 19, 2024

Highest (503.73x)

February 21, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct GrowthICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth1.72%
ICICI Prudential ELSS Tax Saver Fund Direct Plan GrowthICICI Prudential ELSS Tax Saver Fund Direct Plan Growth0.38%
Bandhan Small Cap Fund Direct GrowthBandhan Small Cap Fund Direct Growth0.88%
ICICI Prudential Multicap Fund Direct Plan GrowthICICI Prudential Multicap Fund Direct Plan Growth0.18%
Bandhan Core Equity Fund Direct Plan GrowthBandhan Core Equity Fund Direct Plan Growth0.45%

Shareholding Pattern

InvestorsHoldings %Prev. 2 periods3M change
Promoter Holdings
44.39%
-11.24
Foreign Institutions
9.68%
70.29
Mutual Funds
5.01%
215.03
Retail Investors
38.39%
-9.92
Others
2.53%
2513.43

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Shilpa Medicare Ltd shares.

Shilpa Medicare Ltd (SHILPAMED) share price today is ₹572.3

Shilpa Medicare Ltd is listed on NSE

Shilpa Medicare Ltd is listed on BSE

  • Today’s highest price of Shilpa Medicare Ltd is ₹576.
  • Today’s lowest price of Shilpa Medicare Ltd is ₹523.15.

PE Ratio of Shilpa Medicare Ltd is 143.14

PE ratio = Shilpa Medicare Ltd Market price per share / Shilpa Medicare Ltd Earnings per share

Today’s traded volume of Shilpa Medicare Ltd(SHILPAMED) is 9.23L.

Today’s market capitalisation of Shilpa Medicare Ltd(SHILPAMED) is ₹5151.14Cr.

Shilpa Medicare Ltd(SHILPAMEDPrice
52 Week High
₹576
52 Week Low
₹239.2

Shilpa Medicare Ltd(SHILPAMED) share price is ₹572.3. It is down -0.64% from its 52 Week High price of ₹576

Shilpa Medicare Ltd(SHILPAMED) share price is ₹572.3. It is up 139.26% from its 52 Week Low price of ₹239.2

Shilpa Medicare Ltd(SHILPAMEDReturns
1 Day Returns
45.55%
1 Month Returns
7.13%
3 Month Returns
17.04%
1 Year Returns
98.81%